Document is current
Any future updates will be listed below
-
Authors
Ishibashi, Toru https://orcid.org/0000-0003-3383-9980
Tanioka, Hideki https://orcid.org/0009-0008-7736-8387
Ikehara, Tatsuya https://orcid.org/0009-0000-3263-4700
Kezbor, Safwan https://orcid.org/0009-0002-7441-4057
Sonoyama, Takuhiro https://orcid.org/0009-0005-1734-8446
-
Funding
Funding for this research was provided by:
Shionogi & Co., Ltd.
- License Information
-
More Information
Article History
Accepted: 18 December 2024
First Online: 20 January 2025
Declarations
:
: This study was funded by Shionogi & Co., Ltd. The funder of the study was involved in the study design, data collection, data analysis, and data interpretation.
: Toru Ishibashi, Hideki Tanioka, Tatsuya Ikehara, and Takuhiro Sonoyama are employees of Shionogi & Co., Ltd., and Safwan Kezbor is an employee of Shionogi Inc.
: The study was approved by the Institutional Review Board of ADVARRA (approval date: 10 December, 2021) and conducted in accordance with the Declaration of Helsinki and International Council for Harmonisation guidelines for Good Clinical Practice.
: All participants gave their written informed consent for participation in the study.
: Not applicable.
: The datasets generated and/or analyzed during the current study are available from the corresponding author on reasonable request.
: Not applicable.
: Conceptualization: ToI, HT, TaI, SK, TS; methodology: ToI, TaI; formal analysis: ToI, TaI; investigation: ToI, TaI; interpretation: ToI, HT, TaI, SK, TS; writing (original draft preparation): ToI, TaI; writing (review and editing): ToI, HT, TaI, SK, TS. All authors have read and agreed to the final version of the manuscript.
